Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection
- 1 February 2004
- Vol. 22 (8) , 991-1000
- https://doi.org/10.1016/j.vaccine.2003.09.010
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustainedEuropean Journal of Immunology, 2000
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis CGastroenterology, 1999
- Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzeesArchiv für die gesamte Virusforschung, 1999
- High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis CHepatology, 1998
- A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.Proceedings of the National Academy of Sciences, 1996
- Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.Proceedings of the National Academy of Sciences, 1994
- Vaccination of chimpanzees against infection by thehepatitis C virus.Proceedings of the National Academy of Sciences, 1994
- Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitisHepatology, 1991
- Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virusHepatology, 1990